First, because the number of patients was relatively small and HCC patients who underwent surgical resection were enrolled, it is not sufficient to evaluate the association of PAD2 expression according to each stage of HCC and the role of PAD2 chemoresistance in HCC. This evidence concerns the gene PADI2 and hepatocellular carcinoma.